Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Otago Medical School staff profiles

Dr Mary Sneyd

PositionSenior Research Fellow
DepartmentDepartment of Preventive and Social Medicine (DSM)
QualificationsBSc MB ChB(Otago) PhD
Research summaryCancer epidemiology

Research

The goal of the Hugh Adam Cancer Epidemiology Unit is to conduct high quality research into the causes, impact, burden and consequences of cancer with a particular focus on the causes and consequences of cancer in New Zealand. The HACEU is involved in several national and international studies of the causes, impact, burden and consequences of cancer as well as assessments of cancer incidence, mortality and survival in New Zealand.

Publications

Cox, B., Fitzgerald, P., Austin, R. M., & Sneyd, M. J. (2019). The impact of primary HPV screening on the incidence of cervical cancer in New Zealand. Journal of the American Society of Cytopathology. Advance online publication. doi: 10.1016/j.jasc.2019.03.005

Sneyd, M. J., Cox, B., & Morison, I. M. (2019). Trends in myeloma incidence, mortality and survival in New Zealand (1985–2016). Cancer Epidemiology, 60, 55-59. doi: 10.1016/j.canep.2019.03.006

Cox, B., Bagshaw, P., Talbot, A., & Sneyd, M. J. (2019). Code of Rights and bowel screening. New Zealand Medical Journal, 132(1497), 78-79. Retrieved from https://www.nzma.org.nz/journal

Cox, B., & Sneyd, M. J. (2018). HPV screening, invasive cervical cancer and screening policy in Australia. Journal of the American Society of Cytopathology. Advance online publication. doi: 10.1016/j.jasc.2018.07.003

Nartey, Y., & Sneyd, M. J. (2018). The presenting features of melanoma in New Zealand: Implications for earlier detection. Australian & New Zealand Journal of Public Health. Advance online publication. doi: 10.1111/1753-6405.12815

Chapter in Book - Research

International Agency for Research on Cancer, including Cox, B., & Sneyd, M. J. (2008). Meta-analysis of observational studies on vitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. In Vitamin D and cancer [IARC Working Group Reports: Vol. 5]. (pp. 100-112). Lyon, France: IARC.

^ Top of page

Journal - Research Article

Cox, B., Fitzgerald, P., Austin, R. M., & Sneyd, M. J. (2019). The impact of primary HPV screening on the incidence of cervical cancer in New Zealand. Journal of the American Society of Cytopathology. Advance online publication. doi: 10.1016/j.jasc.2019.03.005

Sneyd, M. J., Cox, B., & Morison, I. M. (2019). Trends in myeloma incidence, mortality and survival in New Zealand (1985–2016). Cancer Epidemiology, 60, 55-59. doi: 10.1016/j.canep.2019.03.006

Cox, B., & Sneyd, M. J. (2018). HPV screening, invasive cervical cancer and screening policy in Australia. Journal of the American Society of Cytopathology. Advance online publication. doi: 10.1016/j.jasc.2018.07.003

Nartey, Y., & Sneyd, M. J. (2018). The presenting features of melanoma in New Zealand: Implications for earlier detection. Australian & New Zealand Journal of Public Health. Advance online publication. doi: 10.1111/1753-6405.12815

Chesang, J., Richardson, A., Potter, J., Sneyd, M. J., & Coope, P. (2016). Prevalence of contraceptive use in New Zealand women. New Zealand Medical Journal, 129(1444), 58-67. Retrieved from http://www.nzma.org.nz/journal

Cox, B., Liu, C.-W., Sneyd, M. J., & Cameron, C. M. (2014). Epidemic of non-Hodgkin lymphoma in New Zealand remains unexplained. Journal of Cancer Epidemiology, 2014, 315378. doi: 10.1155/2014/315378

Sneyd, M. J., Cameron, C., & Cox, B. (2014). Individual risk of cutaneous melanoma in New Zealand: Developing a clinical prediction aid. BMC Cancer, 14, 359. doi: 10.1186/1471-2407-14-359

Sneyd, M. J., & Cox, B. (2013). A comparison of trends in melanoma mortality in New Zealand and Australia: The two countries with the highest melanoma incidence and mortality in the world. BMC Cancer, 13, 372. doi: 10.1186/1471-2407-13-372

Cox, B., & Sneyd, M. J. (2013). Bias in breast cancer research in the screening era. The Breast, 22(6), 1041-1045. doi: 10.1016/j.breast.2013.07.046

Levy, A., Chargari, C., Desrez, G., Leroux, S., Sneyd, M. J., Mozer, P., … Simon, J. M. (2011). Poorer outcome in Polynesian patients with prostate cancer treated with definitive conformational radiation therapy. Radiotherapy & Oncology, 101(3), 502-507. doi: 10.1016/j.radonc.2011.05.075

Cox, B., & Sneyd, M. J. (2011). School milk and risk of colorectal cancer: A national case-control study. American Journal of Epidemiology, 173(4), 394-403. doi: 10.1093/aje/kwq390

Sneyd, M. J., & Cox, B. (2011). Clinical and histologic factors associated with melanoma thickness in New Zealand Europeans, Maori, and Pacific Peoples. Cancer, 117(11), 2489-2498. doi: 10.1002/cncr.25795

Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M. J., … Autier, P. (2011). Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer, 128(6), 1414-1424. doi: 10.1002/ijc.25439

Sneyd, M. J., & Cox, B. (2009). Melanoma in Maori, Asian, and Pacific Peoples in New Zealand. Cancer Epidemiology, Biomarkers & Prevention, 18(6), 1706-1713. doi: 10.1158/1055-9965.EPI-08-0682

Richardson, A., Fletcher, L., Sneyd, M. J., Cox, B., & Reeder, A. I. (2008). The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004. New Zealand Medical Journal, 121(1279). Retrieved from http://journal.nzma.org.nz/journal/121-1279/3189/content.pdf

Sneyd, M. J. (2008). Ethnic differences in prostate cancer survival in New Zealand: A national study. Cancer Causes & Control, 19(9), 993-999.

Sneyd, M. J. (2006/2007). Prevention and early diagnosis of melanoma. New Zealand Pharmacy, 19-20, 22-23.

Sneyd, M. J., & Cox, B. (2006). The control of melanoma in New Zealand. New Zealand Medical Journal, 119(1242). Retrieved from http://journal.nzma.org.nz/journal/119-1242/2169/content.pdf

Cox, B., Sneyd, M. J., Paul, C., & Skegg, D. C. G. (2006). Risk factors for prostate cancer: A national case-control study. International Journal of Cancer, 119, 1690-1694.

Cox, B., & Sneyd, M. (2005). Prospects for cancer control: Colorectal cancer. New Zealand Medical Journal, 118(1221). Retrieved from http://journal.nzma.org.nz/journal/118-1221/1632/content.pdf

Sneyd, M. J., Cox, B., Paul, C. E., & Skegg, D. C. G. (2003). PSA testing and digital rectal examination in New Zealand. Australian & New Zealand Journal of Public Health, 27(5), 502-506.

Cox, B., Sneyd, M. J., Paul, C. E., Delahunt, B., & Skegg, D. C. G. (2002). Vasectomy and risk of prostate cancer. JAMA, 287, 3110-3115.

Sneyd, M. J., Cox, B., Paul, C. E., & Skegg, D. C. G. (2001). High prevalence of vasectomy in New Zealand. Contraception, 64, 155-159.

^ Top of page

Journal - Research Other

Cox, B., Bagshaw, P., Talbot, A., & Sneyd, M. J. (2019). Code of Rights and bowel screening. New Zealand Medical Journal, 132(1497), 78-79. Retrieved from https://www.nzma.org.nz/journal

Chesang, J., Richardson, A., Potter, J., Sneyd, M. J., & Coope, P. (2016). Prevalence of postmenopausal hormone use in New Zealand women. New Zealand Medical Journal, 129(1447), 94-95. Retrieved from http://www.nzma.org.nz/journal

Cox, B., & Sneyd, M. J. (2013). Bowel cancer screening in New Zealand. New Zealand Medical Journal, 126(1385). Retrieved from http://www.nzma.org.nz/journal

Sneyd, M. J., Cameron, C., & Cox, B. (2013). [Letter to the editor]. Australasian Journal of Dermatology, 54(4), e97. doi: 10.1111/ajd.12084

Cox, B., & Sneyd, M. J. (2012). Support for Associate Professor Barendregt's stance against PSA testing of asymptomatic men. New Zealand Medical Journal, 125(1349). Retrieved from http://www.nzma.org.nz/journal

Cox, B., & Sneyd, M. J. (2011). A regional non-melanoma skin cancer (NMSC) collection as part of the National Cancer Registry [Letter]. New Zealand Medical Journal, 124(1346). Retrieved from http://journal.nzma.org.nz/journal/124-1346/4981/content.pdf

Sneyd, M. J., & Cox, B. (2011). Commentary: Decreasing response rates require investigators to quantify and report the impact of selection bias in case-control studies. International Journal of Epidemiology, 40(5), 1355-1357. doi: 10.1093/ije/dyr123

Cox, B., & Sneyd, M. J. (2009). PSA testing in asymptomatic men to diagnose prostate cancer remains experimental [Editorial]. New Zealand Medical Journal, 122(1296). Retrieved from http://journal.nzma.org.nz/journal/122-1296/3640/content.pdf

Sneyd, M. J., Cox, B., Reeder, A., & Richardson, A. (2008). European melanoma incidence: A response to Professor Shaw's melanoma editorial. New Zealand Medical Journal, 121(1285). Retrieved from http://journal.nzma.org.nz/journal/121-1285/3359/content.pdf

More publications...